共 34 条
[11]
Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA., Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimoto´s thyroiditis, Journal of Clinical Endocrinology and Metabolism, 98, pp. 2409-2414, (2013)
[12]
Lee JH, Kim Y, Choi JW, Kim YS., The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis, European Journal of Endocrinology, 168, pp. 343-349, (2013)
[13]
Song E, Jeon MJ, Park S, Kim M, Oh HS, Song DE, Kim WG, Kim WB, Shong YK, Kim TY., Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma, Clinical Endocrinology, 88, pp. 123-128, (2018)
[14]
Pilli T, Toti P, Occhini R, Castagna MG, Cantara S, Caselli M, Cardinale S, Barbagli L, Pacini F., Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes, Journal of Endocrinological Investigation, 41, pp. 703-709, (2018)
[15]
Zitvogel L, Tesniere A, Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion, Nature Reviews Immunology, 6, pp. 715-727, (2006)
[16]
Menicali E, Guzzetti M, Morelli S, Moretti S, Puxeddu E., Immune landscape of thyroid cancers: new insights, Frontiers in Endocrinology (Lausanne), 11, (2020)
[17]
Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Varricchi G, Et al., Immune and inflammatory cells in thyroid cancer microenvironment, International Journal of Molecular Sciences, 20, (2019)
[18]
Zou W., Regulatory T cells, tumour immunity and immunotherapy, Nature Reviews Immunology, 6, pp. 295-307, (2006)
[19]
Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S, Soares FA, Vassallo J, Ward LS., Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma, Clinical Endocrinology, 77, pp. 918-925, (2012)
[20]
Bychkov A, Jung CK., Aberrant expression of CD20 in thyroid cancer and its clinicopathologic significance, Human Pathology, 71, pp. 74-83, (2018)